Précédent|Prochain

Thoughts of Syndrome Differentiation and Treatment and Effect Mechanism of Haoqin Qingdantang in Treating Viral Pneumonia Based on Theory of Treating Different Diseases with Same Therapy

  • role： First author第一作者
  • Affiliation：

    Tianjin University of Traditional Chinese Medicine，Tianjin 301617，China

  • Email：1424762138@qq.com
  • Introduction：彭鑫，在读博士，从事中医肺病临床研究，E-mail：1424762138@qq.com
PENG Xin1,  
  • Affiliation：

    Tianjin University of Traditional Chinese Medicine，Tianjin 301617，China

XU Haotian1,  
  • Affiliation：

    Tianjin University of Traditional Chinese Medicine，Tianjin 301617，China

LIANG Lei1,  
  • Affiliation：

    Tianjin University of Traditional Chinese Medicine，Tianjin 301617，China

LUAN Zheyu1,  
  • Affiliation：

    Tianjin University of Traditional Chinese Medicine，Tianjin 301617，China

WANG Hanxiao1,  
  • Affiliation：

    Tianjin University of Traditional Chinese Medicine，Tianjin 301617，China

ZHANG Yihao1,  
  • Affiliation：

    Tianjin University of Traditional Chinese Medicine，Tianjin 301617，China

YANG Kun1,  
  • role： Corresponding author通信作者
  • Affiliation：

    The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine，Tianjin 300250，China

  • Email：493507647@qq.com
  • Introduction：封继宏，主任医师，博士生导师，从事中医肺病临床研究，E-mail：493507647@qq.com
FENG Jihong2*

résumé

Le traitement commun des différentes maladies est l'essence de la médecine chinoise dans le diagnostic et le traitement, et signifie que lorsque différentes maladies présentent les mêmes changements dans la pathogénie ou les mêmes symptômes, les mêmes principes et méthodes de traitement peuvent être utilisés. En raison de la complexité des types de virus et de leur grande variabilité, le traitement précis et efficace de la pneumonie virale (VP) de différents types a toujours été un point de focalisation de la recherche et un défi difficile de la médecine moderne. VP fait partie de la catégorie des maladies de chaleur, fièvre et épidémies de la médecine ancienne chinoise, et la décoction de l'absinthe et le nettoyage de la bile sont des représentants des remèdes contre la chaleur dans les études sur les brûlures et la chaleur, et ont montré une grande efficacité dans l'intervention dans les cas d'infections virales des voies respiratoires. Sous la direction de la théorie du traitement commun, cette étude a trouvé une séquence organique dans la recherche associée sur l'utilisation de la décoction d'absinthe et de nettoyage de la bile dans le traitement de différents types de VP, et a découvert un mode commun d'humidité-chaleur à différentes étapes du développement de la grippe, du SRAS et de l'infection par le nouveau coronavirus COVID-19, lorsque l'humidité-chaleur est le facteur principal dans ces maladies, l'utilisation de la décoction de l'absinthe et du nettoyage de la bile est particulièrement efficace. Des recherches pharmacologiques récentes ont confirmé que la décoction de l'absinthe et du nettoyage de la bile peuvent inhiber la réplication virale, atténuer les réponses fébriles, inhiber l'expression des médiateurs inflammatoires, réguler l'équilibre immunitaire, et que cette décoction a une excellente activité antivirale, contenant une riche signification scientifique dans le combat contre VP. À partir du point de vue du traitement commun, basé sur la pratique efficace de la décoction d'absinthe et du nettoyage de la bile dans le traitement de différents types de VP et sur les recherches pharmacologiques récentes, ont été découvertes des bases théoriques universelles de la médecine chinoise, et ont été discutées les stratégies de traitement et les mécanismes d'effet de cette décoction dans le traitement de différents types de VP, analysés les mécanismes d'action et les caractéristiques, dans l'espoir de fournir une base et des références pour l'application clinique de la décoction de l'absinthe et du nettoyage de la bile et la recherche dans la médecine moderne

mots-clés

treating different diseases with the same therapy;Haoqin Qingdantang;viral pneumonia;thoughts of syndrome differentiation and treatment;effect mechanism

References

  1. 1.
    GADSBY N J，MUSHER D M. The microbial etiology of community-acquired pneumonia in adults：From classical bacteriology to host transcriptional signatures［J］.Clin Microbiol Rev，2022，35（4）：e0001522.
  2. 2.
    XU Z，ZHAO L，JIANG T J，et al.Viral pneumonia［J］.Infect Dis Inf，2020，33（1）：41-44.
  3. 3.
    ZHOU F，WANG Y，LIU Y，et al. Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults：A multicentre prospective registry study from the CAP-China Network［J］.Eur Respir J，2019，54（2）：1802406.
  4. 4.
    Expert Consensus Group for Emergency Diagnosis and Treatment of Adult Acute Respiratory Virus Infection.Expert consensus on emergency diagnosis and treatment of adult acute respiratory virus infection［J］.J Emerg Med，2021，30（12）：1417-1428.
  5. 5.
    ZHONG W，WU F，WU J，et al.New progress in the treatment of viral pneumonia［J］.Chin J Tubercul Respir Dis，2022，45（1）：121-126.
  6. 6.
    LIU H，ZHU W X，HUO L L，et al.A Meta-analysis of treating respiratory tract infection with the Haoqin Qingdan decoction［J］.Clin J Chin Med，2021，13（22）：126-130.
  7. 7.
    CHEN Y H，ZHONG J X，WU Z B，et al.Observation on the curative effect of Huohao Qinqingdan decoction combined with Tanreqing in the treatment of influenza virus fever［J］.Hubei J Tradit Chin Med，2010，32（3）：45-46.
  8. 8.
    SANG F M，LIU X G，CHEN H. Efficacy of Haoqinqingdan decoction for damp influenza viral pneumonia and analysis of immune parameters and NF-κB levels［J］.Chin J Nosocomiol，2014（24）：6050-6051，6054.
  9. 9.
    WANG B，XU B，FAN Y L，et al. Experience in treatment of COVID-19 by elimination of pathogens through purgation and diuresis［J］.Chin J Exp Tradit Med Form，2020，26（19）：53-59.
  10. 10.
    WANG F F，CHEN J X，HOU Y J，et al. Identifying the main pattern as the key to treating different diseases with the same method［J］.J Beijing Univ Tradit Chin Med，2017，40（12）：978-981.
  11. 11.
    LUO L P.Exploration of Zhongjing's "same disease，different treatment" and "different disease，same treatment" thoughts［J］.World Latest Med Inform，2016，16（45）：42-43.
  12. 12.
    Editorial Committee of the Dictionary of Traditional Chinese Medicine.Concise dictionary of traditional Chinese medicine［M］.Beijing：People's Medical Publishing House，1979：384.
  13. 13.
    XU H.Analysis of the prescription rules of "treating different diseases with the same treatment" in Traditional Chinese Medicine Internal Medicine［J］.Chin J Bas Med Tradit Chin Med，2015，21（6）：737-738.
  14. 14.
    GUO S Y，SONG D，GAO W F，et al.A brief discussion on the same treatment of different diseases with Shenqi pills［J］.China J Tradit Chin Med Pharm，2020，35（2）：764-767.
  15. 15.
    CHE Y J，PANG L J，LV X D，et al.Thoughts and methods of scientific prevention and treatment of viral pneumonia with traditional Chinese medicine［J］.China J Tradit Chin Med Pharm，2020，35（12）：5922-5926.
  16. 16.
    JIA L，LIU X F，JING Z W，et al. Thoughts on differentiation and treatment of viral pneumonia by stages of Xuanfei Sanxie［J］.Chin J Basic Med Traditl Chin Med，2023，29（12）：2101-2104.
  17. 17.
    BI J Y，ZHANG G J，CUI Y L，et al.Multi-target intervention effect of Ganlu Xiaodu Dan on mouse model of viral pneumonia with damp-heat syndrome［J］.Lishizhen Med Mater Med Res，2019，30（8）：1840-1844.
  18. 18.
    LIU L T，LI J，PENG G Y，et al. Analysis of the similarities and differences among severe acute respiratory syndrome，influenza A H1N1 and corona virus disease 2019 based on the theory of TCM［J］.J Liaoning Univ Tradit Chin Med，2021，23（1）：208-212.
  19. 19.
    CHEN Y B，LIN X H，LIN L，et al.92 cases of hospitalized patients with influenza viral pneumonia in analysis of TCM syndromes［J］.China J Tradit Chin Med Pharm，2016，31（6）：2342-2344.
  20. 20.
    ZENG Y W.A brief discussion on the source of SARS coronavirus and the treatment of "Shire Yidu"［J］.J Emerg Syndromes Tradit Chin Med，2012，21（7）：1105-1106.
  21. 21.
    GEN J W，WEN X D，YUAN C J，et al.Research on the traditional Chinese medicine disease name，etiology and pathogenesis of severe acute respiratory syndrome（SARS）［J］.J Hunan Coll Tradit Chin Med，2003，23（5）：59-61.
  22. 22.
    SHI K H，ZHE Z，SUN Y S，et al.Treatment of COVID-19 from Qingre Huashi based on "eliminating evil is the top priority"［J］.Shanghai J Tradit Chin Med，2020，54（8）：9-15.
  23. 23.
    SHEN Y L.Explanation and understanding of the formula and symptoms of Haoqin Qingdan decoction［J］.China J Tradit Chin Med Pharm，2015，30（10）：3562-3566.
  24. 24.
    HAN X M，MA C J，XIN Y，et al. Haoqin Qingdan decoction from the pharmacodynamics of the role of innovative advantage［J］.Chin Arch Tradit Chin Med，2011，29（1）：81-83.
  25. 25.
    ZUO M Y，XU C L，YANG Y.Application of Haoqin Qingdan decoction in exogenous fever［J］.J Emerg Syndromes Tradit Chin Med，2012，21（8）：1274.
  26. 26.
    GONG P Q，SHEN Y L，JIANG Y Y. Treatment of gastric precancerous lesions in chronic atrophic gastritis patients with Haoqin Qingdan decoction（蒿芩清胆汤） based on damp-heat theory［J］.Liaoning J Tradit Chin Med，2024，51（4）：76-80.
  27. 27.
    YAN T W，LV H. Effect of using Haoqin Qingdan decoction in the treatment of patients with community acquired pneumonia（damp-heat and internal depression type）and its influence on serum inflammatory factors and blood gas indexes［J］.J Sichuan Tradit Chin Med，2021，39（5）：81-84.
  28. 28.
    CHEN Y H，ZHONG J X，LIN P Z，et al.Evaluation of the therapeutic effect of Haoqin Qingdan mixture on upper respiratory tract viral infections with damp heat syndrome［J］.Tianjin J Tradit Chin Med，2010，27（5）：365-366.
  29. 29.
    LIU H，ZHU W X，HUO L L，et al.A Meta-analysis of treating respiratory tract infection with the Haoqin Qingdan decoction［J］.Clin J Chin Med，2021，13（22）：126-130.
  30. 30.
    YANG M，WANG Y，YUE Y，et al. Traditional Chinese medicines as effective agents against influenza virus-induced pneumonia［J］.Biomed Pharmacother，2022，153：113523.
  31. 31.
    TANG Z H，PAN Y，LIU Y，et al.Effect of Three TCM therapies on AQP4 expression and inflammatory factor of mice with H1N1 damp-heat syndrome［J］.Jiangsu J Tradit Chin Med，2010，42（8）：73-75.
  32. 32.
    GAO J，LIU Y，LAN Q，et al.Clinical effect observation on influenza treated by methed of eliminating heat and wetness evil［J］.Prac Clin J Integr Tradit Chin West Med，2010，10（3）：1-2，4.
  33. 33.
    HUI D，ZUMLA A. Severe acute respiratory syndrome：Historical，epidemiologic，and clinical features［J］.Infect Dis Clin North Am，2019，33（4）：869-889.
  34. 34.
    LU Y R，LIU Q Q，JIAO Y Q，et al.Analysis of traditional Chinese medicine diagnosis and treatment of two types of pandemic respiratory infectious diseases：Coronavirus and influenza virus［J］.Beijing J Tradit Chin Med，2021，40（1）：7-11.
  35. 35.
    The National Administration of Traditional Chinese Medicine organized experts.Technical plan for traditional Chinese medicine prevention and treatment of atypical pneumonia（trial）［J］.Tianjin J Tradit Chin Med，2003（z1）：8-9.
  36. 36.
    LIU X Y，WU D W，ZHENG X X.Exploring the diagnosis and treatment rules of SARS from the experience of treating febrile diseases［J］.Chin J Ethnomed Ethnopharm，2016，25（5）：50-51.
  37. 37.
    LU R，ZHAO X，LI J，et al. Genomic characterisation and epidemiology of 2019 novel coronavirus：Implications for virus origins and receptor binding［J］.Lancet，2020，395（10224）：565-574.
  38. 38.
    WANG Y G ，QI W S，MA J J，et al. Clinical features and syndrome differentiation of novel coronavirus pneumonia in traditional Chinese medicine［J］.J Tradit Chin Med，2020，61（4）：281-285.
  39. 39.
    LI B，CONG X D，MIAO Q，et al. Analysis of medical cases of coronavirus disease-2019 treated with Haoqin Qingdantang［J］.Chin J Exp Tradit Med Form，2020，26（14）：1-6.
  40. 40.
    HU M L，DONG R L，CHEN G，et al.Clinical case of severe novel coronavirus pneumonia treated with integrated traditional Chinese and Western medicine［J］.Chin J Integr Tradit Chin West Med，2020，40（2）：228-230.
  41. 41.
    XIE L Y，WANG X P，WU Z B，et al.Exploration of the immune inflammatory mechanism of Haoqin Qingdan decoction on damp heat syndrome of viral pneumonia in mice［J］.J New Chin Med，2010，42（11）：113-115.
  42. 42.
    MO R G，HAN X M，XIN Y，et al.Experimental study on the inhibiting flu virus action of Haoqin Qinggan decoction［J］.Tradit Chin Med Res，2005，18（5）：16-18.
  43. 43.
    ROTH J，BLATTEIS C M. Mechanisms of fever production and lysis：Lessons from experimental LPS fever［J］.Compr Physiol，2014，4（4）：1563-1604.
  44. 44.
    SU F Z，BAI C X，ZHANG W S，et al. Antipyretic effect and mechanism of bovine bile［J］.Chin Tradit Herb Drug，2024，55（10）：3363-3374.
  45. 45.
    TAN Y Q，REN C X，HAN X M.Orthogonal experiment on screening the antipyretic formula of Haoqin Qingdan Tang［J］.J Liaoning Univ Tradit Chin Med，2007，9（2）：124-125.
  46. 46.
    LU Z G，HAN X M.Studies on the antipyretion and anti-inflammation effects of Haoqinqingdantang decotion［J］.Chin Arch Tradit Chin Med，2005，23（3）：454-455.
  47. 47.
    ZHANG Q，LENARDO M J，BALTIMORE D. 30 years of NF-κB：A blossoming of relevance to human pathobiology［J］.Cell，2017，168（1/2）：37-57.
  48. 48.
    DENG L，NIE J，PANG P，et al.Comparative study on the therapeutic effect of Xinjia Xiangru decoction on mice with influenza virus pneumonia in hot and humid environment［J］.J New Chin Med，2016，48（2）：235-238.
  49. 49.
    LAI P H，LIN P Z，WANG X P，et al. Effects of Haoqinqingdan DECOCTION and its disassembled recipes on damp-heat syndrome of influenza viral pneumonia and NF-κB expression［J］.China J Tradit Chin Med Pharm，2011，26（9）：2074-2076.
  50. 50.
    GAO Z X，WANG X P，LIN P Z，et al. Effect of Haoqin Qingdan decoction and its modified prescriptions on inflammatory factors in viral pneumonia mice with damp-heat syndrome［J］.J Guangzhou Univ Tradit Chin Med，2011，28（2）：171-175.
  51. 51.
    CIESIELSKA A，MATYJEK M，KWIATKOWSKA K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling［J］.Cell Mol Life Sci，2021，78（4）：1233-1261.
  52. 52.
    JIN Z Q，ZHANG W B，CHEN X，et al. Role and mechanism of CD14-TLR4-NF-κB signaling pathway in LPS induced ALI/ARDS［J］.Anhui Med Pharm J，2022，26（4）：643-647.
  53. 53.
    LUO H H，ZHANG F X，WU W，et al. Haoqin Qingdan decoction（蒿芩清胆汤） and ribavirin therapy downregulate CD14 and toll-like receptor 4 in febrile disease with dampness-heat syndrome in a mouse model［J］.Chin J Integr Med，2016，22（10）：768-773.
  54. 54.
    WU Z，ZHENG Y，SHENG J，et al. CD3+CD4-CD8-（double-negative） T cells in inflammation，immune disorders and cancer［J］.Front Immunol，2022，13：816005.
  55. 55.
    SHEN S，JI Z S，ZHANG Y，et al. Study on the efficacy of Th17/Treg，Th1/Th2 combined with NEWS2 score in predicting the progression of pneumonia［J］.Translat Med J，2024，13（1）：48-53.
  56. 56.
    LIU Y，WU Z B，LIN X D，et al. Influence of Haoqin Qingdan decoction on immune injury in influenza viral pneumonia of dampness-heat syndrome in mouse［J］.Acta Univ Tradit Med Sin Pharmacol Shanghai，2011，25（2）：51-55.
  57. 57.
    GAO J，LIU Y，WANG Q，et al. Eliminating heat and wetness evil therapy for influenza virus infection［J］.Inter Med Health Guid New，2010，16（11）：1291-1294.
  58. 58.
    LUAN Z Y，WANG H X，PENG X，et al.Immunity-inflammation mechanism of viral pneumonia and traditional Chinese medicine treatment based on theory of healthy Qi and pathogenic Qi［J］.Chin J Exp Tradit Med Form，2025，31（2）：239-247.
  59. 59.
    WANG Z Y，WANG X，ZHANG D Y，et al. Traditional Chinese medicine network pharmacology：Development in new era under guidance of network pharmacology evaluation method guidance［J］.China J Chin Mater Med，2022，47（1）：7-17.
  60. 60.
    LIANG L X，PAN H D，HUANG Y F，et al.The scientifc foundation of Chinese herbal medicine against COVID-19［J］.Engineering，2020，6（10）：94-112.
  61. 61.
    ZHAO K B，CHEN Y Z，GU H T，et al. Network pharmacology and molecular docking to explore the mechanism of Haoqin Qingdan decoction in the treatment of COVID-19［J］.Guangdong Chem Ind，2023，50（16）：32-36.
  62. 62.
    LI F. Identifying the monarch medicine in formulas［J］.J Nanjing Univ Tradit Chin Med，2021，37（4）：481-484.
  63. 63.
    NIE C，TRIMPERT J，MOON S，et al. In vitro efficacy of Artemisia extracts against SARS-CoV-2［J］.Virol J，2021，18（1）：182.
  64. 64.
    LU Z G，WAN Q，MENG J，et al. Preparation of hydroxypropyl-β-cyclodextrin inclusion complex of volatile oil in artemisiae annuae herba and analysis of its antiviral activity［J］.Chin J Exp Tradit Med Form，2018，24（18）：11-15.
  65. 65.
    WANG P，CHEN S，HUANG X T，et al. Therapeutic effects of artesunate on cytomegalovirus pneumonia in mice［J］.Acta Pharmaceutica Sinica，2020，55（11）：2651-2656.
  66. 66.
    ZHOU Y J，ZHANG J，WU B，et al. Therapeutic effect of artesunate on influenza A viral pneumonia［J］.J Sichuan Univ：Med Sci，2022，53（6）：1055-1060.
  67. 67.
    CU R H，LI Y L，WANG C X，et al. Effect of Scutellariae Radix on expression of inflammatory cytokine protein and gene in lung of mice with viral pneumonia caused by influenza virus FM1 infection［J］.China J Chin Mater Med，2019，44（23）：5166-5173.
  68. 68.
    WAN Q F，GU L G，YIN S J，et al. Effect of baicalin on cell apoptosis FAS/FAS-L system of pneumonia mice lung tissue infected with FM1［J］.Chin Pharmacol Bul，2011，27（11）：1555-1559.
  69. 69.
    WAN Q F，GU L G，YIN S J，et al. Protection effect of baicalin on lung injury of mice infected with influenza FM1［J］.China J Tradit Chin Med Pharm，2011，26（12）：2848-2851.
  70. 70.
    YANG M L，DU X K，KAN X X，et al. Respiratory infectious diseases and tissue "damage-repair" balance：Pathological characteristics，treatment，and characteristics of traditional Chinese medicine［J］.China J Chin Mater Med，2021，46（24）：6366-6376.

Lire l'article complet

The above content is generated by Large Model Translation. The translated content is for reference only. We do not assume any commercial or legal responsibilty for any consequences arising from the use of our website